CN104324389B

CN104324389B - The blood shearing force response protein 1 function and application in treatment atherosclerosis

Info

Publication number: CN104324389B
Application number: CN201410512511.1A
Authority: CN
Inventors: 李红良; 赵光年; 王丕晓; 邓克穷
Original assignee: Wuhan University WHU
Current assignee: Wuhan University WHU
Filing date: 2014-09-29
Publication date: 2017-01-04
Anticipated expiration: 2034-09-29

Abstract

The invention discloses a kind of blood shearing force response protein 1(RECS1) function and application in treatment atherosclerosis, belong to function and the application of gene.The present invention is with ApoE^‑/‑Mice and RECS1^‑/‑ApoE^‑/‑Mice is experimental subject, obtains Atherosclerosis Model by high fat diet induction, and result shows and ApoE^‑/‑Mice contrasts, and RECS1 genetic flaw significantly reduces the plaque area of aorta, strengthens the stability of aortic sinus speckle, significantly reduces inflammatory reaction.This shows that RECS1 function in atherosclerosis is mainly reflected in promote that Aortic Plaque is formed, and particularly facilitates atherosclerosis.For the function of RECS1, RECS1 can be used for screening prevention, alleviate and/or treating atherosclerotic medicine as drug targets, and the inhibitor of RECS1 can be used for preparation prevention, alleviates and/or treat atherosclerotic medicine.

Description

Blood shearing force response protein 1 Function and application in treatment atherosclerosis

Technical field

The invention belongs to function and the application of gene, be specifically related to a kind of blood shearing force response protein 1(RECS1) function and application in treatment atherosclerosis, specifically RECS1 in preparation prevention, alleviate and/or treat in atherosclerotic medicine and apply.

Background technology

Cardiovascular and cerebrovascular disease be main lethal in many developed countries because of, sickness rate and fatality rate in China raise the most year by year.The basis of cardiovascular and cerebrovascular disease is atherosclerosis (Atheosclersisis, AS), and atherosclerosis can make ductus arteriosus wall thicken, hardening, luminal stenosis, causes a lot of cardiocerebrovasculaevents events to occur.And the coronary artery acute stenosis that causes of the rupturing of atherosclerosis unstable spot, hematoblastic gathering and thrombosis and obturation are to cause acute coronary syndrome (acute Coronary syndrome, ACS) major reason.

Atherosclerosis is multiple gene, a kind of chronic inflammation disease that risk factor and immunologic mechanism participate in jointly, inflammatory and immune response locally and systemically plays an important role in atherosclerosis generation evolution, inherent immunity and adaptive immunity participate in regulating atherosclerotic lesion jointly, show as big on pathology, medium-sized artery many places speckle is formed, it is apt to occur in blood shunt, the regions such as tremulous pulse bending and arterial branch, its characteristics of lesion is that in blood, lipid deposits at endarterium, cause inner membrance stove fibrous thickening, focus deep is the medicated porridge sample material formed by slough and extracellular lipid pond.Atheromatous plaque also exists panimmunity cell, wherein most commonly seen with macrophage and T cell, in addition with a small amount of dendritic cell (Dentritic cell, DC), natural killer cell (natural killer Cell, NK cell) and mastocyte (mast cell) etc., occasionally there is bone-marrow-derived lymphocyte.

The macroscopic damage of atherosclerosis earliest period is fatty streaks, is mainly made up of the Macrophage derived foamy cell that intake of a large amount of cholesterol.Mononuclear cell in blood circulation is attached to reactive endothelial cells at tremulous pulse damageable zone, starts the formation of fatty streaks, and the chemistry that the mononuclear cell sticked the most locally is produced is ingratiated with the attraction of molecule and moved under inner membrance, and is divided into macrophage further.A large amount of cholesterol esters, in macrophage inner accumulated, form foam cell, and this is atherogenesis characteristic pathological physiological process in early days.Atherosclerotic is multifactor coefficient result, and the atherosclerosis risk sexual factor having now been found that is a lot, but related pins is the most undesirable to treatment and control effect, and blood fat reducing and anti-inflammatory treatment are current topmost remedy measures.

There is the whole process of development through atherosclerosis in inflammatory reaction, inflammatory reaction is also to cause atheromatous plaque to rupture one of principal element.NF-κ B is initially to find in Mus mature B cell and granulocyte tumor and the regulon of named nucleus Kappa light chain gene expression.Research finds, all there is the NF-κ B of activation in the various kinds of cell such as the macrophage of atherosclerotic lesion, smooth muscle cell, endotheliocyte.With High-fat diet LDLR mRNA defect (LDLR^-/-) mice, the activation of nuclear Factor-Kappa B can be found in early days in the endotheliocyte of mouse aorta root, and it was found that this position is developing progressively as atherosclerotic plaque [1].Suppression NF-κ B signal pathway activated then contributes to alleviating atherosclerosis.Curcumin, by the expression of NF-κ B during suppression AS, the generation of suppression inflammatory factor, alleviates AS inflammatory reaction [2].

RECS1(responsive to centrifugal force and shear stress gene 1) it is blood shearing force response protein.Nojima laboratory [3] reports the transcriptional expression of blood shear stress induction RECS1 the earliest, and clones cDNA and the aminoacid sequence obtaining RECS1.People RECS1 is 1 311 amino acid whose 7 transmembrane proteins, has the highest homology with Lifeguard and glutamate binding proteins.The mice of RECS1 gene knockout is susceptible to suffer from aorta cystic medionecrosis and is presented with large artery trunks di time old, show that [4] are reinvented in the possible growth participating in modulating vascular of RECS1.RECS1 is tumor necrosis factor receptor 2 (tumor neucrosisfactor receptor 2, TNFR2) conjugated protein, have been reported that the l cell showing stable expression RECS1 shows certain toleration to the agonistic antibody that TNFR2 is special, show that RECS1 may participate in the regulation and control [5] of TNF-α signal.Recent study result shows, RECS1 combines TNFR1, and the nuclear transcription factor-kappa B (NF-κ B) suppressing overexpression TNFR1 to induce activates, thus negative regulation TNF-α signal [6].Based on the studies above basis, it is considered that RECS1 may play key player in the characteristic pathological physiological process of atherogenesis, but its biological function in the characteristic pathological physiological process of atherogenesis and possible mechanism of action not yet illustrate.

Mice and genetic engineering mice resource are one of most important animal models in field such as current disease mechanisms research, gene functional research, medicine initiative, are also the necessary conditions of these field innovation researches.Each molecule link during utilizing genetic engineering mice to manage for Atheromatosis is studied, and to the molecular mechanism illustrated in atherosclerosis generation evolution, the molecular target finding treatment of atherosclerosis has great importance.

[list of references]

1、Hajra L, Evans AI, Chen M, et al. The NF-kappa B signal transduction pathway in aorticendothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci U S A, 2000, 97(16):9052-9057.

2, Wang Chunbin, tall and big in, Yin Yuehui, etc. the impact that hyperlipemia rabbit aorta NF-κ B, VCAM-1, VEGF are expressed by curcumin. Chinese patent medicine, 2007,29 (8): 1127-1129.

3, H.Yoshisue, K.Suzuki, A.Kawabatal, Atherosclerosis 162,323 (Jun, 2002).

4、Zhao H1, Ito A, Sakai N, Matsuzawa Y, et al. RECS1 is a negative regulator of matrix metalloproteinase-9 production and aged RECS1 knockout mice are prone to aortic dilation. Circ J. 2006 May; 70(5): 615-24.

5, Cai Cifeng, the NF-κ B of Wu Mingjiang, Liao Zhi brave .RECS1 negative regulation tumor necrosis factor receptor 2 mediation activate.Chinese biological chemistry and molecular biosciences journal, 2010.

6, Liao Zhiyong. centrifugal force and shear stress response protein 1 are the new regulatory factors of tumour necrosis factor receptor-1.Chinese biological chemistry and molecular biosciences journal, 2011.

Summary of the invention

It is an object of the invention to determine the expression of RECS1 and atherosclerotic mutual relation, it is provided that one for preventing, alleviate and/or treat the new application of atherosclerotic target gene RECS1.

The purpose of the present invention is achieved through the following technical solutions:

Expression and the atherosclerotic relation of the RECS1 that present invention determine that are as follows:

1. RECS1 gene knockout significantly reduces atherosclerotic plaque area

The present invention is with ApoE gene knockout (ApoE^-/-) mice is with RECS1/ApoE is dual-gene knocks out (RECS1^-/-ApoE^-/-) mice is experimental subject, obtains atherosclerosis mouse model (AS) by low fat feedstuff and high lipid food diet induced respectively.Result shows ApoE^-/-And RECS1^-/-ApoE^-/-Mice passes through low fat feed diet, and aorta tree has a small amount of speckle to be formed；After high lipid food diet, plaque area dramatically increases, RECS1^-/-ApoE^-/-The aorta tree of mice, aortic sinus plaque area all significantly less than ApoE^-/-Mice (Fig. 1-2).

2. RECS1 gene knockout is obviously enhanced the stability of aortic sinus speckle

The present invention is with ApoE gene knockout (ApoE^-/-) mice is with RECS1/ApoE is dual-gene knocks out (RECS1^-/-ApoE^-/-) mice is experimental subject, obtain atherosclerosis mouse model (AS) by high lipid food diet induced, the stability of aortic sinus speckle is studied.Result shows that RECS1 gene knockout substantially reduces content and the area of necrotic center of macrophage in aortic sinus speckle, increases content and the collagen component content of smooth muscle cell in speckle, enhances the stability (Fig. 3) of aortic sinus speckle.

3. RECS1 gene knockout significantly reduces inflammatory reaction

The present invention is with ApoE gene knockout (ApoE^-/-) mice is with RECS1/ApoE is dual-gene knocks out (RECS1^-/-ApoE^-/-) mice is experimental subject, obtains atherosclerosis mouse model (AS) by high lipid food diet induced, the expression to the inflammatory factor of aortic sinus speckle is studied.Result shows that RECS1 gene knockout significantly reduces the proinflammatory factors such as ICAM-1 and IL-6 of aortic sinus speckle, increases the expression (Fig. 4) of the anti-inflammatory factors such as IL-10.

When being understood generation atherosclerosis by result above, RECS1 genetic flaw decreases plaque area, strengthens the stability of aortic sinus speckle, significantly reduces inflammatory reaction.Therefore RECS1 has the effect promoting that atherosclerosis occurs development, prevents and treats atherosclerotic novel targets for research and New Policy provides theoretical foundation and Clinical Basis.

Therefore, RECS1 gene as drug target, can build In vitro cell model or the animal model of RECS1 gene overexpression, is used for screening prevention, alleviate and/or treating atherosclerotic medicine；RECS1 gene also can design and prepare prevention as the target gene in gene therapy, alleviate and/or treat atherosclerotic medicine and/or biological reagent, is reached prevention by technique for gene engineering, is alleviated and/or treat atherosclerotic purpose.Such as with RECS1 as target gene, design may interfere with double-strand siRNA that RECS1 expresses, and after being chemically synthesized, is injected into human body and makes RECS1 gene silencing treat atherosclerosis by the method that RNA disturbs；Can also design and build the mutant of RECS1, enter cell, the substrate specificity of competition RECS1 original shape after injection, thus suppress the function of RECS1, play therapeutic purposes；In addition, In vitro cell model or the animal model of RECS1 gene overexpression with RECS1 for shot design micromolecular compound inhibitor, can also be utilized, by screening, find wherein can the molecule of specificity suppression RECS1, thus provide new therapeutic molecules for atherosclerotic treatment.

Above-mentioned functions for RECS1, it is provided that RECS1 prevents as drug targets in screening, alleviates and/or treat the application in atherosclerotic medicine.

Above-mentioned functions for RECS1, it is provided that the inhibitor of RECS1 prevents in preparation, alleviates and/or treat the application in atherosclerotic medicine.

One is prevented, is alleviated and/or treat atherosclerotic medicine, comprises the inhibitor of RECS1.

The inhibitor of described RECS1 is preferably the rna interference vector of siRNA, RECS1 gene of RECS1 gene, the antibody of RECS1 and other can suppress the one in the inhibitor that RECS1 expresses.

The present invention has such advantages as relative to prior art and effect:

1. present invention discover that the New function of RECS1 gene, i.e. RECS1 can promote atherosclerotic effect.

2. promote atherosclerotic function based on RECS1, provide target for developing atherosclerotic medicine.

3. The inhibitor of RECS1 can be used for preparation prevention, alleviates and/or treat atherosclerotic medicine.

Accompanying drawing explanation

Fig. 1 is ApoE^-/-And RECS1^-/-ApoE^-/-The aorta tree oil red O stain of mice and plaque area cartogram, result shows that RECS1 gene knockout significantly reduces the plaque area (NS: there was no significant difference) of aorta tree.

Fig. 2 is ApoE^-/-And RECS1^-/-ApoE^-/-Mouse aorta hole HE dyeing and plaque area statistics block diagram, result shows that RECS1 gene knockout significantly reduces plaque area (*: the p ＜ 0.05 vs HFD ApoE of aortic sinus^-/-Group).

Fig. 3 is ApoE^-/-And RECS1^-/-ApoE^-/-Necrotic center, collagen component, macrophage and the dyeing of smooth muscle cell content and result statistics block diagram in the aortic sinus speckle of mice, result shows that RECS1 gene knockout substantially reduces content and the area of necrotic center of macrophage in aortic sinus speckle, increases content and collagen component content (*: the p ＜ 0.05 vs HFD ApoE of smooth muscle cell in speckle^-/-Group).

Fig. 4 is ApoE^-/-And RECS1^-/-ApoE^-/-The expression immunofluorescence dyeing of the inflammatory factor such as ICAM-1, IL-6, IL-10 and result statistics block diagram in the aortic sinus speckle of mice, result shows that RECS1 gene knockout significantly reduces the expression of proinflammatory factor ICAM-1 and IL-6 of aortic sinus speckle, increases expression (*: the p ＜ 0.05 vs HFD ApoE of anti-inflammatory factors IL-10^-/-Group).

Detailed description of the invention

Below in conjunction with embodiment and accompanying drawing, the present invention is described in further detail, but embodiments of the present invention are not limited to this.

Animal for research and raising

Laboratory animal kind, sex, week old and source: ApoE gene knockout (ApoE^-/-) mice is with RECS1/ApoE is dual-gene knocks out (RECS1^-/-ApoE^-/-) mice, male, 8 week old, body weight 19-25g.ApoE knock out mice (ApoE^-/-, purchased from Jackson Laboratory, article No. 002052)；RECS1^-/-ApoE^-/-Mice is obtained by RECS1 knock out mice (purchased from RIKEN company of Japan, article No.: RBRC01772) and the hybridization of ApoE knock out mice.

Laboratory animal feed formula: (HFD, purchased from Fukang bio tech ltd of Beijing China, by AIN-76 for high lipid food A Western Diets formula, percent of calories: protein 15.8%, fat 40%, carbohydrate 44.2%)；Low fat feedstuff (NC, purchased from Fukang bio tech ltd of Beijing China, article No. D12450B): percent of calories: protein 20%, carbohydrate 70%, fat 10%.

Animal feeding and environmental condition: all of experiment mice is all raised at angiocardiopathy institute of Wuhan University SPF level Animal House (credit number: SYXK(Hubei Province): 2009-0053).Alternately illumination in every 12 hours, temperature 24 ± 2 DEG C, humidity 40%-70%, mice freely drinks water feed.

Embodiment 1 rat aorta is atherosis, and model (AS) obtains

1. laboratory animal packet: select 8 week old, body weight 19-25g, male, ApoE^-/-Mice and RECS1^-/-ApoE^-/-Mice, gives high lipid food (Western Diets, HFD) respectively and low fat feedstuff (Normal chow, NC) is raised, ApoE^-/-HFD group, ApoE^-/-NC group, RECS1^-/-ApoE^-/-HFD group, RECS1^-/-ApoE^-/-NC group totally 4 groups, often organize each 20.

2. Atherosclerosis Model is by high lipid food induction operating process:

Use ApoE^-/-Mice and RECS1^-/-ApoE^-/-Mice, sets up AS model, carries out phenotype correlation analysis, specifies the effect that RECS1 gene pairs atheromatosis plays.Mice is from the beginning of 8 week old, and the omnidistance high lipid food of HFD group is fed 28 weeks and put to death and collect sample, and the omnidistance low fat forage feed of NC group is put to death and collects sample for 28 weeks.

Embodiment 2 AS model mice plaque area measures

1. mice end tissue sampling eventually

Mice feeds high fat or low fat feedstuff until when 28 weeks, weighing, using 3% pentobarbital sodium, 90mg/kg anesthetized mice, it is fixed on material drawing board with syringe needle, moistens mice skin of chest abdomen with gauze, cut off thoracic cavity with eye scissors, expose heart, cut off right auricle, the syringe needle of transfusion device is lunged left ventricle, slowly inject 10-15mL PBS with 50mL syringe, treat that right auricle effluent is limpid, change 4% paraformaldehyde and continue to inject 10-15mL.After perfusion terminates, remove splanchnocoel internal organs, only retain heart.Mice is placed under microscope, separates fascia, fatty tissue around aortic arch, cut heart in ascending aorta initial part, cut off in the middle part of thoracic aorta, and cut off at about 3mm under neck summation clavicle, aortic arch is put in above-mentioned EP pipe.

2. aorta tree plaque area measures

Aorta tree is placed in fixing → pure water rinsing 30min → 60% isopropanol overnight in 4% paraformaldehyde and processes 10 min → oil red O dye liquor (company sigma, article No. 00625) dyeing 60min → 60% isopropyl alcohol 1min × 3 time are to removing remaining outer wall fat → be laid on black dissection stencil plate by tremulous pulse dye under clean background → anatomical lens, take pictures with digital camera after dyeing, and use Image-Pro Plus 6.0 image analysis software carries out plaque area quantitative determination (oil red O stock solution=0.5 gram oil red O+100 milliliter 100% isopropanol, oil red O dye liquor (working solution): V(oil red O stock solution)/V(H₂O)=3/2).

Aorta tree plaque area (%)=speckle gross area/aorta tree gross area * 100%.

3. pathological tissue processes

Prepared by 3.1 paraffin specimens

In 4% paraformaldehyde overnight fixing after, aortic arch filter paper is carefully wrapped, in case spilling from embedding frame gap.Flowing water puts into dewaterer after rinsing 30min, 30% ethanol 15min → 50% ethanol 15min → 75% ethanol 15min → 85% ethanol 15min → 95% ethanol 15min → 100% ethanol 15min → 100% ethanol 15min → dimethylbenzene 15min → dimethylbenzene 15min → paraffin 30min → paraffin 30min.After aortic arch has been dehydrated, taking out from dewaterer, aortic arch lies low in paraffin.

3.2 aortic tissue sections

Use microtome that aortic sinus paraffin specimen is cut into slices (slice thickness 5 μm).

4. aortic sinus plaque area measures

nullHaematoxylin eosin stains (HE dyeing): take aortic sinus paraffin white tiles 65 DEG C baking 30 minutes → dimethylbenzene 5 minutes × 3 times → 100% ethanol 1 minute → 95% ethanol 1 minute → 70% 1 minute → pure water of ethanol rinsing (not hanging with the globule on slide as standard) → get rid of the moisture on most microscope slide，Haematoxylin solution (Zhuhai shellfish rope，BA-4021) 5 minutes → tap water rinse (removing haematoxylin loose colour on slide) → 1% acidic alcohol 1-3 second → tap water rinse (removing acidic alcohol on slide) → Scott liquid (sodium bicarbonate 0.35g is contaminated，Magnesium sulfate 2g，Distilled water 100mL) 1 minute → tap water embathes (removing the Scott liquid on slide) → get rid of the moisture being all on slide，Yihong solution (Zhuhai shellfish rope，BA-4024) 10 seconds → pure water of dyeing rinsing (removing the loose colour in Yihong on slide) → 70% ethanol once → 95% ethanol once → 100% ethanol 30 seconds，3 times → dimethylbenzene 2 minutes，3 times → take advantage of dimethylbenzene the most dry time mounting (with bubble-free of cutting into slices as principle) → fume hood in dry up，Microscope is taken pictures.

HE dyeing picture statistics: directly by Image-Pro Plus 6.0 image analysis software circle aortic sinus plaque area.

By aorta tree oil red O stain can substantially assess that atheromatous plaque on whole piece blood vessel formed number, distribution situation and the size of plaque area.Fig. 1 is mice AS model aorta posterior tree oil red O stain result figure, and brachiocephalic trunk and aortic sinus are the most obvious positions of atheromatous plaque, ApoE^-/-And RECS1^-/-ApoE^-/-Mice passes through low fat feed diet, and aorta tree just has a small amount of speckle to be formed, and RECS1^-/-ApoE^-/-The plaque area of mice and ApoE^-/-Mice is without significant difference；After high fat diet, plaque burden dramatically increases, RECS1^-/-ApoE^-/-The aorta tree plaque area of mice is significantly less than ApoE^-/-Mice.Fig. 2 is mice AS model posterior sinus of Valsalva HE coloration result figure, and result shows RECS1 after high fat diet^-/-ApoE^-/-The plaque area of the aortic sinus of mice is significantly less than ApoE^-/-Mice.Result above shows that RECS1 gene knockout significantly reduces atherosclerotic plaque area.

The mensuration of embodiment 3 AS model mice plaque stability

1. the size of aortic sinus necrotic center measures

Haematoxylin eosin stains (HE dyeing), method, with embodiment 2.4, is chosen the tissue microscope containing cholesterol crystal, acellular core fibre structure and is taken pictures.

The area estimation of necrotic center: use Image-Pro Plus 6.0 image analysis software circle necrotic center area.

2. aortic sinus collagen component assay:

Picro-Sirius red (PSR) dyes, mainly comprise the following steps: take aortic sinus paraffin white tiles 55 DEG C baking 30min → dimethylbenzene 2min, 3 times → 100% ethanol 1min → 95% ethanol 1min → 70% ethanol 1min → flowing water rinses 10min → distilled water 1min → mass fraction 0.2% phosphomolybdic acid 2min → 0.1% sirius red picric acid solution and drips in tissue, dye in wet box 90min → remove residul liquid-removing → 0.01N hydrochloric acid 4s → 70% ethanol 1 time → 90% ethanol 1 time → 100% ethanol 30s, 3 times → dimethylbenzene 2min, 3 times → take advantage of the most dry coverslip mounting immediately of dimethylbenzene, microscope is taken pictures.

Collagen ratio measuring: use Image-Pro Plus 6.0 image analysis software circle redness area of collagen, collagen ratio (%)=area of collagen/plaque area * 100%.

3. the expression of aortic sinus macrophage and smooth muscle cell mark measures

Immunofluorescence dyeing detection aortic sinus macrophage marker CD68, smooth muscle cell mark SMA(Smooth Muscle Actin) expression.Required anti-information a: CD68(MCA1957; 1:100; rat;AbD Serotec), SMA(ab5694; 1:100; rabbit;Abcam)；Required two anti-information: Alexa Flour 568 goat anti-rat IgG(A11077；Invitrogen), Alexa Fluor 488-conjugated goat anti-rabbit IgG(A11008；Invitrogen).

Mainly comprise the following steps:

1) roasting sheet: aortic sinus paraffin white tiles is placed in more than 30min in baking box.

2) dewaxing: dimethylbenzene 5min × 3 time.

3) hydration: 100% ethanol 5min × 2 time；95% ethanol 5min；70% ethanol 5min；ddH₂O embathes 5min × 2 time.

4) citrate tissue antigen recovery (Pressure method): take a certain amount of pH6.0 citrate antigen retrieval working solution in repairing in box, put in pressure cooker, big fire is heated to boiling, tissue slice after dewaxing hydration is placed in reparation box, cover pot cover, buckle pressure valve, continue to be heated to jet, after starting timing 5min, take out and repair box；Room temperature places 20min, takes out section after natural cooling.

5) ddH₂O rinses 5min × 2 time, and PBS rinses 5min × 2 time.

6) groupization stroke circle, drips 10% sheep blood serum (GTX27481, GeneTex) and closes, and closes 60min for 37 DEG C in wet box.

7) abandoning confining liquid, the one of dropping proper proportion dilution resists, 4 DEG C of overnight incubation, and 37 DEG C of rewarming 30min discard one and resist, and PBS washes 10min × 3 time.

8) dropping two resists, and hatches 60min for 37 DEG C in wet box, discards two and resists, and PBS embathes 5min × 3 time.

9) SlowFade Gold antifade reagent with DAPI(S36939, Invitrogen) mounting.

10) viewed under fluoroscopy, takes pictures.

Fluorescent quantitation is added up: use Image-Pro Plus 6.0 image analysis software to measure Positive Cell Counts, CD68/SMA(%)=positive cell number/plaque area * 100%.

Macrophage is most important cell component in speckle, differentiate after it is subcutaneous in mainly having blood circulation mononuclear cell to enter, Monocytes/Macrophages can secrete multiple adhesion, chemotactic factor such as cell adhesion molecule (ICAM-1), MCAF (MCP-1) etc., promote the entrance of speckle inner cell, in addition macrophage also can secrete multiple matrix metalloproteinase (MMPs), reduce area of collagen in speckle, thus destroy the stability of speckle；Smooth muscle cell can secrete various kinds of cell substrate, is the cell source of atheromatous plaque endocrine collagen, and Main Function is to repair destroyed cellular stromal component thus plays a protective role；Collagen component is most important extracellular matrix in speckle, is also the main component of fibrous cap, has the impact of anti-blood flow and prevents the effect of plaque rupture, is also the important evaluation index safeguarding plaque stability.

Fig. 3 is ApoE^-/-Mice and RECS1^-/-ApoE^-/-The analysis result figure of the aortic sinus speckle inclusions of mice.The visible RECS1 of aortic sinus HE dyeing^-/-ApoE^-/-The necrotic center area of mice is significantly less than ApoE^-/-Mice；PSR coloration result shows the model after high fat diet, RECS1^-/-ApoE^-/-The collagen ratio of group mice is apparently higher than ApoE^-/-Mice；Immunofluorescence sends out observation macrophage marker CD68 at RECS1^-/-ApoE^-/-Expression in mice speckle is then substantially less than ApoE^-/-Mice；Smooth muscle cell mark SMA is at RECS1^-/-ApoE^-/-Expression in mice speckle is apparently higher than ApoE^-/-Mice.Result above shows that RECS1 gene knockout substantially reduces content and the area of necrotic center of macrophage in aortic sinus speckle, increases content and the collagen component content of smooth muscle cell in speckle；RECS1 gene knockout can strengthen the stability (Fig. 3) of aortic sinus speckle.

The mensuration of inflammatory Cytokines Expression in embodiment 4 AS model mice speckle

The expression of the inflammatory factors such as immunofluorescence dyeing detection aortic sinus ICAM-1, IL-6, IL-10.Required anti-information a: ICAM-1(AF796；1:100；goat；R&D systems), IL-6(AF-406-NA；1:100；goat；R&D systems), IL-10(AF-217-NA；1:100；goat；R&D systems)；Required two anti-information: Alexa Flour 568 donkey anti-goat IgG(A11057；Invitrogen).

Mainly comprise the following steps: see embodiment 3.3.

Fluorescent quantitation is added up: uses Image-Pro Plus 6.0 image analysis software that positive cell carries out absorbance (IOD) and measures.

Inflammatory reaction is one of principal element of causing atheromatous plaque to rupture.The a large amount of cytokine of proinflammatory cytokine secretion such as interleukin-6 (IL-6), interleukin 10 (IL-10) etc. may result in the activation of endotheliocyte, the hypertrophy of smooth muscle cell, apoptosis and the progress of medicated porridge sample pathological changes.Adhesion, chemotactic factor that impaired endotheliocyte and Monocytes/Macrophages are secreted are the key factors that transmitting inflammation cell is assembled to atheromatous plaque.The expression being observed the inflammatory factors such as ICAM-1, IL-6, IL-10 by immunofluorescence dyeing is changed, result shows that RECS1 gene knockout significantly reduces the expression of proinflammatory factor ICAM-1, IL-6 in aortic sinus speckle, increases IL-10 and presses down the expression (Fig. 4) of inflammatory factor.

Above-described embodiment result shows, ApoE^-/-Mice and RECS1^-/-ApoE^-/-Mice issues lively pulse atherosclerosis, and ApoE in the induction of high fat diet^-/-Mice is compared, and the dual-gene Aortic Plaque area knocking out rear mice of RECS1/ApoE substantially reduces, and plaque stability also increases, and inflammatory reaction substantially alleviates.These results indicate that RECS1 can remarkably promote the formation of Aortic Plaque and atherosclerotic develop.Present invention demonstrates that RECS1 has important deterioration effect in Atherosclerosis Model, its inhibitor can be used for the medicine of preparation treatment atheromatosis.

Above-described embodiment is the present invention preferably embodiment; but embodiments of the present invention are also not restricted to the described embodiments; the change made under other any spirit without departing from the present invention and principle, modify, substitute, combine, simplify; all should be the substitute mode of equivalence, within being included in protection scope of the present invention.

Claims

1.RECS1 prevents as drug targets in screening, alleviates and/or treat the application in atherosclerotic medicine, it is characterised in that: described application is the purpose of non-diagnostic and treatment；Described screening prevents, alleviates and/or treat atherosclerotic medicine, refers to the medicine that screening can suppress RESC1 to express.